Since HUS risk-assessment based on multiple virulence markers remains impractical and unaffordable to perform in routine patient care, PCR or antigen-based detection of Stx1 and Stx2 can be used as a surrogate marker, confirming infection with Shiga toxin-producing strains. Here, STX2 is linked to infection.